Cancer Immunotherapy Program Event Listing

1 - 1 of 1

The CAR-T Revolution 3 Years After FDA Approval

Torie CART

Three years after FDA approval of the first CAR-T therapy, Dr. Grupp will review outcomes data and provide an update on advancements and new trials in the field of cancer immunotherapy for patients with relapsed acute lymphoblastic leukemia (ALL).

Dec 15, 2020 from 5 p.m. - 6:30 p.m. (ET)